Cardio DiagnosticsCDIO
Market Cap: 10.6M
About: Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.
Employees: 9
Fund manager confidence
Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
0% more funds holding
Funds holding: 14 [Q4 2023] → 14 (+0) [Q1 2024]
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.17% less ownership
Funds ownership: 8.07% [Q4 2023] → 7.9% (-0.17%) [Q1 2024]
44% less capital invested
Capital invested by funds: $4.12M [Q4 2023] → $2.3M (-$1.82M) [Q1 2024]
Research analyst outlook
2 Wall Street Analysts provided 1 year price forecasts over the past 6 months
2 analyst ratings
Benchmark Bruce Jackson | 327%upside $2 | Speculative Buy Maintained | 6 Jun 2024 |
Benchmark Bruce Jackson | 188%upside $1.35 | Speculative Buy Maintained | 19 Apr 2024 |